Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gender-specific differences in haemostatic parameters and their influence on blood loss in bimaxillary surgery. | Clin Oral Investig | 2022 | 35013785 | PubTator, text mining | PubMed |
| Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation. | J Biol Chem | 2022 | 35007530 | PubTator, text mining | PubMed |
| Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics. | Clin Proteomics | 2022 | 34996345 | PubTator, text mining | PubMed |
| Factor IX(a) inhibitors: an updated patent review (2003-present). | Expert Opin Ther Pat | 2022 | 34991418 | PubTator, text mining | PubMed |
| Risk and Management of Intracerebral Hemorrhage in Patients with Bleeding Disorders. | Semin Thromb Hemost | 2022 | 34991167 | PubTator, text mining | PubMed |
| Methylprednisolone, venous thromboembolism, and association with heparin to 30 days in hospital survival in severe Covid-19 pneumonia. | BMC Pulm Med | 2022 | 34986821 | PubTator, text mining | PubMed |
| Characterization and first-in-human clinical dose-escalation safety evaluation of a next-gen human freeze-dried plasma. | Transfusion | 2022 | 34951486 | PubTator, text mining | PubMed |
| Structural insights into the activation of blood coagulation factor XI zymogen by thrombin: A computational molecular dynamics study. | Biophys Chem | 2022 | 34923393 | PubTator, text mining | PubMed |
| Emerging biological functions of ribonuclease 1 and angiogenin. | Crit Rev Biochem Mol Biol | 2022 | 34886717 | PubTator, text mining | PubMed |
| Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19. | Blood Adv | 2022 | 34861681 | PubTator, text mining | PubMed |
| Factor V east Texas variant causes bleeding in a three-generation family. | J Thromb Haemost | 2022 | 34847292 | PubTator, text mining | PubMed |
| Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. | Toxicology | 2022 | 34813904 | PubTator, text mining | PubMed |
| Genetic analysis of compound heterozygous pathogenic variants of the F11 gene in two Chinese patients with hereditary factor XI deficiency. | Blood Coagul Fibrinolysis | 2022 | 34799507 | PubTator, text mining | PubMed |
| F11 Gene Duplication Causes Elevated FXI Plasma Levels and Is a Risk for Venous Thrombosis. | Thromb Haemost | 2022 | 34781376 | PubTator, text mining | PubMed |
| Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation. | Nat Rev Immunol | 2022 | 34759348 | PubTator, text mining | PubMed |
| Milvexian, an orally bioavailable, small-molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits. | J Thromb Haemost | 2022 | 34752670 | PubTator, text mining | PubMed |
| A proposal for managing bleeding in patients on therapeutic factor XI(a) inhibitors. | J Thromb Haemost | 2022 | 34735741 | PubTator, text mining | PubMed |
| Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa. | J Thromb Haemost | 2022 | 34714969 | PubTator, text mining | PubMed |
| Diagnosing rare bleeding disorders. | Blood Coagul Fibrinolysis | 2022 | 34654013 | PubTator, text mining | PubMed |
| Reflex factor coagulation testing in patients with an unexplained prolonged aPTT: An institutional retrospective review. | Int J Lab Hematol | 2022 | 34623751 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=43